DelfaGLP-1 Atlas

← Trials/Trial dossier/NCT06666049

POCUS

Recruiting

Gastric POCUS for Airway Management in Patients Using Glucagon-like Peptide-1 Receptor Agonist (Multicentric)

Asset

GLP-1 / incretin class catch-all

Listed sites

2

Recruiting sites

2

Enrollment

39

estimated

Study population

Perioperative / gastric aspiration risk

Key I/E criterion

—

Primary endpoint

•Gastric Ultrasound

Footprint

Where this trial recruits

Site locations as reported to ClinicalTrials.gov. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT06666049
Org study IDPOCUS

Timeline

Milestones

Study start2024-10-21actual
Study first posted2024-10-30actual
Last update posted2026-05-05actual
Primary completion2026-11-01estimated
Study completion2026-12-01estimated

Assets

Investigational agents

GLP-1 / incretin class catch-all

Study populations

Who this study enrolls

Perioperative / gastric aspiration risk

Eligibility

Who can enroll

Minimum age18 Years
Maximum age90 Years
SexAll
Sampling methodNon probability sample

Study population text

The reference population will consist of patients undergoing scheduled surgery with a conventional preoperative fasting period (at least 6 hours).

Inclusion criteria

Adults patients ,ASA I-III, taking GLP-1 analog medications, undergoing scheduled surgery.

Exclusion criteria

1. - History of esophagogastric pathology or previous abdominal surgery.

2. - Hiatal hernia/gastroesophageal reflux disease.

3. - Autonomic nervous system disorders.

4. - Neurological or neuromuscular diseases.

5. - Use of medications/drugs that affect autonomic regulation and delay gastric emptying (opioids) or potentiate it (prokinetics).

6. - Pregnancy.

7. - Presence of arrhythmias.

Endpoints (4)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Coverage by outcome category

Weight & body composition
3
Other clinical outcomes
1

Weight & body composition

3 endpoints
Secondary/protocol endpoint

weight in kilograms

Time frame:Immediately prior to induction of anesthesia

Body weight, absolute change (kg)

descriptive, improvement

Secondary/protocol endpoint

Height in centimeters

Time frame:Immediately prior to induction of anesthesia

descriptive

Secondary/protocol endpoint

BMI in kg/m^2

Time frame:Immediately prior to induction of anesthesia

descriptive

Other clinical outcomes

1 endpoint
Primary/protocol endpoint

Gastric Ultrasound

Time frame:Immediately prior to induction of anesthesia

descriptive

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2
Snapshot dateJuly 1, 2026
Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)
Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 1, 2026 snapshot.